生物医药专刊

慢性心力衰竭的诊疗现状

展开
  • ①中山大学附属第一医院 心内科,广州 510080;②中山大学 国家卫生健康委员会辅助循环重点实验室,广州 510080

收稿日期: 2021-11-14

  网络出版日期: 2022-05-05

Diagnosis and treatment of chronic heart failure

Expand
  • ①Department of Cardiology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China;②NHC Key Laboratory of Assisted Circulation, Sun Yat-sen University, Guangzhou 510080, China

Received date: 2021-11-14

  Online published: 2022-05-05

摘要

心力衰竭是各种心脏疾病的终末阶段,其高死亡率和再住院率一直是治疗的难点。经过多年的临床和基础研究,心力衰竭的诊疗进展迅速。现行的国家心力衰竭指南将心力衰竭分为多个类别,对每个类别都有具体的诊疗方法。文章根据中国、美国和欧洲的心力衰竭指南,从流行病学、病因与诱因以及各类心力衰竭的诊疗、并发症和预后管理等方面对心力衰竭进行全面介绍。简要分析并整理现有的基础研究和临床试验,以期使更多读者了解该疾病。

本文引用格式

孙君怡, 薛睿聪, 梁玮昊, 董吁钢, 刘晨 . 慢性心力衰竭的诊疗现状[J]. 自然杂志, 2022 , 44(2) : 126 -148 . DOI: 10.3969/j.issn.0253-9608.2022.02.007

Abstract

Heart failure is the terminal stage of various heart diseases, and its high mortality and re-hospitalization rate are always been a difficulty in treatment. After years of clinical and basic research, the diagnosis and treatment of heart failure have updated
rapidly. The current national heart failure guidelines have subdivided heart failure into multiple categories, and have specific diagnosis and treatment methods for each category. This review provides a comprehensive introduction to chronic heart failure in terms of epidemiology, etiology and triggers, diagnosis and treatment of heart failure, complications and prognosis management based on the Chinese, American and European heart failure guidelines. It also makes a brief analysis and outlook for existing clinical trials, in order to make more readers understand the disease.
文章导航

/